Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    18698359 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed AMA1-C1/Alhydrogel + CpG 7909 for Malaria
Condition: Plasmodium Falciparum Malaria
Interventions: Biological: AMA1-C1/Alhydrogel®;   Biological: CPG 7909 Oligodeoxynucleotide (VaxImmune®)

Indicates status has not been verified in more than two years